Results 131 to 140 of about 1,482 (173)
Some of the next articles are maybe not open access.
Treatment of alopecia areata partim universalis with efalizumab
Journal of the American Academy of Dermatology, 2006Alopecia areata (AA) is considered an autoimmune disease targeted at hair follicles with T-lymphocytes playing an important role in the pathogenesis. Treatment of AA, particularly the totalis and universalis subtypes, is often difficult and remains a therapeutic challenge.
Ursula, Kaelin +3 more
openaire +4 more sources
Alopecia areata universalis in a dog
Veterinary Dermatology, 2015BackgroundAlopecia areata is a T‐cell mediated autoimmune disease that occurs in humans and various other mammalian species. When the disease progresses to total alopecia it is defined as alopecia areata universalis (AAU), although this outcome has only been described in humans.Hypothesis/objectivesTo describe a case of canine alopecia areata ...
Ginel, Pedro J. +4 more
openaire +3 more sources
Alopecia areata universalis in an infant
Journal of Cutaneous Medicine and Surgery, 2001Background: Alopecia areata (AA) is common during childhood and rarely reported in infants. The four reported cases of AA in infants all exhibited circumscribed patches of alopecia that appeared at birth or shortly thereafter. Objective:
J A, LaRow +4 more
openaire +2 more sources
Renbök Phenomenon in a Patient With Alopecia Areata Universalis
Archives of Dermatology, 2012The Renbök phenomenon, or reverse Koebner phenomenon, was first reported in 1991 by Happle et al,1 who described 4 patients with extensive alopecia areata of the scalp with hair growth within plaques of psoriasis. Three additional cases have subsequently been reported,2-4 and the term was later extended to include patients with mosaic phenomena, one ...
Ruano, J. (J.) +7 more
openaire +2 more sources
JAMA Dermatology, 2023
ImportancePrevalences of alopecia areata (AA), alopecia totalis (AT), and alopecia universalis (AU) are poorly established.ObjectiveTo estimate overall and subgroup prevalences of AA and its subtypes.Design, Setting, and ParticipantsThis cross-sectional study using electronic records comprising the Explorys database (Watson Health, IBM Corporation ...
Nene, Sy +3 more
openaire +2 more sources
ImportancePrevalences of alopecia areata (AA), alopecia totalis (AT), and alopecia universalis (AU) are poorly established.ObjectiveTo estimate overall and subgroup prevalences of AA and its subtypes.Design, Setting, and ParticipantsThis cross-sectional study using electronic records comprising the Explorys database (Watson Health, IBM Corporation ...
Nene, Sy +3 more
openaire +2 more sources
Alopecia Areata Universalis Elicited during Treatment with Adalimumab
Dermatology, 2008Adalimumab is a fully humanized recombinant anti-tumour-necrosis-factor (TNF-α) monoclonal antibody which has been approved for rheumatoid arthritis, active ankylosing spondylitis, psoriatic arthritis and Crohn’s disease. We report a case of alopecia areata (AA) universalis occurring 6 months after administration of adalimumab monotherapy in a patient ...
Pelivani N +4 more
openaire +3 more sources
Estimation of CD3, CD4, and CD8 in Iraqi patients with alopecia areata and alopecia universalis
Journal of Cosmetic Dermatology, 2021AbstractBackgroundAlopecia areata is considered to be an autoimmune disease characterized by T‐cell response and production of cytokines around the anagen stage.Aim of the studyThe aim of this study was to assess T cells in blood using immune biomarkers (CD3, CD4, and CD8) in patients with AA and AU compared with healthy individuals.Materials and ...
Sahar Taha Hatif Aldaffaie +2 more
openaire +2 more sources
Alopecia areata universalis Sparing Nevus flammeus
Dermatology, 2005Alopecia areata is a common form of nonscarring hair disorder of unclear etiology. Cases with alopecia areata sparing congenital melanocytic nevi have been described. It is explained by the Renbök phenomenon or inverse Köbner phenomenon, which refers to normal hair growth in the psoriatic lesions observed in patients with psoriasis and alopecia areata.
openaire +2 more sources
Journal of the American Academy of Dermatology, 1985
Twenty patients with alopecia universalis, alopecia semiuniversalis and alopecia areata were studied for their immune parameters. Fourteen of them received an oral treatment with Isoprinosine, a synthetic immunomodulator. Ten patients showed the presence of several autoantibodies.
Lowy, Marie Cecile +3 more
openaire +3 more sources
Twenty patients with alopecia universalis, alopecia semiuniversalis and alopecia areata were studied for their immune parameters. Fourteen of them received an oral treatment with Isoprinosine, a synthetic immunomodulator. Ten patients showed the presence of several autoantibodies.
Lowy, Marie Cecile +3 more
openaire +3 more sources

